Over 2,000 real rulings β analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous pharmacist alleged an Apo-go nurse advisor changed Parkinsonβs medicines without authority and failed to inform PDNSs. Panel found the programme a…
BMJ trial-tracker data suggested 1 Bayer βdueβ EUCTR trial lacked results (98.6% reported). Bayer showed the trial was withdrawn before enrolment and…
PMCPA case AUTH/3082/9/18 (Bristol-Myers Squibb) concerned clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (Code year…
BMJ analysis flagged a historic UK-site trial with results not posted to EUCTR by the EC guideline deadline. Panel found a Clause…
PMCPA found breaches after a Revolade IFR appointment email implied use in myelofibrosis and an internal brand-plan email referenced offβlicence presurgery use…
Anonymous complaint about a Novo Nordisk symposium invitation email. Most allegations were not upheld, but the opt-in wording for receiving promotional material…
A journalist challenged a Galvus EU approval press release for implying βfew/limited treatment optionsβ in renally impaired type 2 diabetes and citing…
A consultant alleged a ProStrakan rep misled his secretary by implying they were working together on symptom control guidelines. Accounts conflicted and…
AbbVie admitted Humira ads (online banner and journal print) used out-of-date prescribing information (May 2011) instead of the current Dec 2012 version.…
A GP complained that a Trajenta (linagliptin) advert was sent to his NHS email. The Panel found evidence he had opted in…
GSK admitted two Benlysta promotional case studies were emailed to 48 HCPs before certification. Emails lacked integral prescribing information, had a broken…
Ex-employee alleged archived investor presentations (1999β2006) made false/imbalanced claims about Seroquel and weight. Panel and Appeal Board ruled no breach of Clause…
Napp self-reported 3 BuTrans follow-up promotional emails sent after agency calls where consent to email was unclear. Panel found breach for one…
Rosemont disclosed that five long-standing sales staff did not sit the ABPI Medical Representatives Examination after an exemption ended in 2006. PMCPA…
Anonymous health professional alleged MSD promoted unlicensed oncology pipeline medicines via exhibition panels at ESGO 2013. Panel had concerns (esp. trial recruitment…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week β free.